SURPASS-AP-Combo is consistent with the results of the global SURPASS series of research, which further proves that the pathophysiology of diabetes in Chinese patients is consistent with that of global patients, which is the basis for the simultaneous research and development of new drugs in China and the world, and also provides solid evidence support for giving Chinese patients the opportunity to use the latest diabetes treatment drugs and their clinical application in China as soon as possible
Leadership Action: All DDAs to publish the names of their CEO, and contact phone, email and postal addresses
A substance needs only satisfy two of three criteria to be added to the Prohibited List: (a) that it has the potential to enhance sport performance
The lawsuits involve claims that Ozempic and other GLP-1 receptor agonist drugs, including Wegovy and Mounjaro, caused serious gastrointestinal injuries such as gastroparesis, or stomach paralysis
Starting compounded semaglutide during perimenopause offers a significant advantage: you can prevent weight gain from accumulating rather than trying to reverse years of metabolic changes